Communications Biology (Jan 2021)

Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome

  • So-mi Kang,
  • Min-Ho Yoon,
  • Jinsook Ahn,
  • Ji-Eun Kim,
  • So Young Kim,
  • Seock Yong Kang,
  • Jeongmin Joo,
  • Soyoung Park,
  • Jung-Hyun Cho,
  • Tae-Gyun Woo,
  • Ah-Young Oh,
  • Kyu Jin Chung,
  • So Yon An,
  • Tae Sung Hwang,
  • Soo Yong Lee,
  • Jeong-Su Kim,
  • Nam-Chul Ha,
  • Gyu-Yong Song,
  • Bum-Joon Park

DOI
https://doi.org/10.1038/s42003-020-01540-w
Journal volume & issue
Vol. 4, no. 1
pp. 1 – 11

Abstract

Read online

Kang, Park and colleagues develop and demonstrate the effects of a new drug candidate for treatment of Hutchinson-Gilford progeria syndrome pathologies. Progerinin extends the life span of mice used to model this disease and induces histological and physiological improvements.